Using a new formulation technique, researchers were able to more than double drug loading of a hydrophobic active pharmaceutical ingredient in tablets. Thus, the new formulation method may lead to smaller pills delivering the same therapeutic benefit.
MIT chemical engineers have devised a new way to formulate hydrophobic drugs by turning them into a nanoemulsion, which can be poured into a mold and dried into tablets. The nanoemulsion can also be used to form small particles, seen in the vials [Credit: Felice Frankel].
Chemical engineers have devised a novel process for incorporating hydrophobic active pharmaceutical ingredients (APIs) into tablets or other drug formulations such as capsules and thin films. Their technique, which involves creating a nanoemulsion of the drug and then crystallising it, allowed them to load more drug into each tablet and thus could be used to make smaller dosage forms, making swallowing of tablets easier and enhancing patient compliance.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
According to the researchers who developed the method, roughly 60 percent of the drugs currently on the market, including common anti-inflammatories such as ibuprofen, ketoprofen and naproxen, and up to 90 percent of drugs in development have hydrophobic APIs. As a result of their insolubility in water, these hydrophobic APIs can be difficult to formulate into tablets because they need to be milled into nanocrystals to be effectively absorbed by the human body.
Most formulations (eg, tablets, capsules or films) consist of an API combined with excipients, other compounds which both stabilise the drug and control how it is released in the body. Currently, to create formulations of hydrophobic APIs, pharma companies mill the compound down to nanocrystals, which are easier for human cells to absorb. These nanocrystals are then blended with excipients. One commonly used excipient in these formulations is methylcellulose, which dissolves easily in water and thus helps drugs to be released faster in the body.
However, according to the Massachusetts Institute of Technology (MIT)’s chemical engineers, this formulation technique had many inefficiencies. Liang-Hsun Chen, an MIT graduate student and the lead author of the new study, explained: “The milling step is very time consuming and energy intensive – and the abrasive process can cause changes in active ingredient properties, which can undermine the therapeutic effects.”
In their research Chen and Patrick Doyle, the Robert T. Haslam Professor of Chemical Engineering and the senior author of the paper published in Advanced Materials, wanted to develop a more efficient way to combine hydrophobic drugs with methylcellulose. They did this by forming a nanoemulsion – a mixture of nanometre diameter oil droplets suspended in water.
To create their nanoemulsion, the researchers took a hydrophobic drug called fenofibrate, which is used to help lower cholesterol, and dissolved it in an oil called anisole. Then they combined this oil phase with methylcellulose dissolved in water, using ultrasonication (sound waves) to create the nanoscale oil droplets. Methylcellulose benefits this method because it is amphiphilic, meaning that it can bind to both the oil droplets and the water, and in doing so helps to keep the mixture from separating. It is also thermoresponsive – a key property for the next stage, known as thermogelling.
Once the thermoresponsive nanoemulsion was formed, the researchers can transform it into a gel by dripping the liquid into a heated water bath. As each drop hits the water, it solidifies within milliseconds. The size of the particles can be controlled by changing the size of tip that is used to drip the liquid into the water bath.
“The particle formation is nearly instantaneous, so everything that was in your liquid drop gets converted to a solid particle without any loss,” Doyle stated. “After drying, we have nanocrystals of fenofibrate uniformly distributed in the methylcellulose matrix.”
Smaller pills, more drug
Once the nanocrystal-loaded particles are formed, they can be crushed into powder and then compressed into tablets, using standard drug manufacturing techniques. Alternatively, the researchers can pour their gel into molds, instead of dripping it into water, allowing them to create drug tablets in any shape.
In the study, the researchers were able to improve drug loading of fenofibrate using their nanoemulsion technique, increasing the drug concentration from roughly 25 percent (found in currently available formulations) to approximately 60 percent. They also revealed that the technique could be easily adapted to load even higher concentrations by increasing the ratio of oil to water in the emulsion.
“This can enable us to make more effective and smaller drugs that are easier to swallow, and that can be very beneficial for many people who have difficulty swallowing drugs,” Chen commented.
They also explained that this method could also be used to make thin films — a type of drug formulation that has become more widely used in recent years and is especially beneficial for children and older people. Once a nanoemulsion is made, the researchers can dry it into a thin film that has drug nanocrystals embedded in it.
“The flexibility of the system is that we can choose different oils to load different drugs and then make it into a nanoemulsion using our system. We do not need to do a lot of trial-and-error optimisation because the emulsification process is the same,” Chen stated.
Calvin Sun, a professor of pharmaceutics at the University of Minnesota, who was not involved in the research, describes the nanoemulsion technique as an “elegant process.” He commented: “It is impressively flexible in terms of accommodating a wide range of drug loadings and tuneable drug release rate. If implemented at the commercial scale, it will have a far-reaching impact in the development of oral solid dosage forms of poorly soluble drugs.”
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.